-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.50145.9% Upside
Anixa Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Anixa Biosciences, Inc.?
Anixa Biosciences, Inc. has been rated by research analysts at H.C. Wainwright, Chardan Capital in the past 90 days.